CAS 1420071-30-2

(E)-5-(5-((3-(4-bromophenyl)-2-imino-4-oxothiazolidin-5-ylidene)methyl)furan-2-yl)isoindoline-1,3-dione

Description:

The chemical substance known as (E)-5-(5-((3-(4-bromophenyl)-2-imino-4-oxothiazolidin-5-ylidene)methyl)furan-2-yl)isoindoline-1,3-dione, with the CAS number 1420071-30-2, is characterized by its complex molecular structure, which includes multiple functional groups and heterocycles. This compound features a thiazolidinone moiety, which is known for its biological activity, particularly in medicinal chemistry. The presence of a bromophenyl group suggests potential for interactions in biological systems, while the isoindoline-1,3-dione framework may contribute to its reactivity and stability. The (E) configuration indicates a specific geometric arrangement around a double bond, which can influence the compound's physical properties and biological activity. Overall, this substance may exhibit interesting pharmacological properties, making it a candidate for further research in drug development and therapeutic applications. Its synthesis and characterization would typically involve advanced organic chemistry techniques, and its behavior in biological systems would require thorough investigation through in vitro and in vivo studies.

Synonyms:

• Bioymifi

Bioymifi

CAS: 1420071-30-2

Formula: C₂₂H₁₂BrN₃O₄S

Purity: 97%

Color and Shape: Solid

Molecular weight: 494.3174

Ref: IN-DA001HJG

Bioymifi

CAS: 1420071-30-2

Bioymifi

Purity: ≥98%

Molecular weight: 494.32g/mol

Ref: 54-BUP07045

Bioymifi

CAS: 1420071-30-2

Bioymifi (DR5 Activator), a novel TRAIL activator, binds to DR5's ECD, inducing DR5 aggregation and stimulating cell apoptosis. Cost-effective and quality-assured.

Formula: C₂₂H₁₂BrN₃O₄S

Purity: 98% - 99.79%

Color and Shape: Solid

Molecular weight: 494.32

Ref: TM-T2065

Bioymifi

CAS: 1420071-30-2

Bioymifi is a synthetic compound, functioning as a biological agent, which is derived from natural precursor molecules using advanced chemical synthesis techniques. It acts as a modulator of cellular pathways, specifically influencing apoptosis by selectively activating certain proteins within the cellular environment. This mode of action is particularly useful in elucidating the mechanisms of cell death and survival, thereby contributing to a deeper understanding of cellular processes.

Bioymifi is principally employed in laboratory research focused on cell signaling and apoptosis. It is widely applied in the study of diseases where apoptotic dysregulation is a central feature, such as in cancer or neurodegenerative disorders. Additionally, it is utilized in developing therapeutic strategies, serving as a model compound to inspire the creation of new drugs targeting apoptotic pathways.

Formula: C₂₂H₁₂BrN₃O₄S

Purity: Min. 95%

Molecular weight: 494.32 g/mol

Ref: 3D-VGC07130